Volume 9, Issue 3 (2023)                   Pharm Biomed Res 2023, 9(3): 169-172 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Law S K. Effectiveness of 5-aminolevulinic Acid Combined with Curcumin Mediating Photodynamic Therapy. Pharm Biomed Res 2023; 9 (3) :169-172
URL: http://pbr.mazums.ac.ir/article-1-528-en.html
Faculty of Science and Technology, The Technological and Higher Education Institute of Hong Kong, Tsing Yi, Hong Kong.
Abstract:   (763 Views)
5-aminolevulinic acid (5-ALA) is the mitochondria metabolite produced from glycine and succinyl-CoA, which is converted to protoporphyrin IX (PpIX) by the conjugation of eight itself molecules forming the “heme” group in a porphyrin ring (Figure 1) [1]. The PpIX is used as a photosensitizer (PS) with an absorption wavelength of 410 nm, and 5-ALA acts as a precursor or prodrug for PpIX in photodynamic therapy (PDT). Exogenous administration of excessive amounts of 5-ALA increases the production of PpIX during heme biosynthesis. It is eliminated after 24-48 h with a lower risk of long-term photosensitivity [2]. However, 5-ALA PDT has several disadvantages, including the concentration of ALA is affected by its absorption and pharmacokinetics that are not fully covered the treatment area [3-5], as well as the limited depth of tumor penetration and caused pain symptoms [6].
Full-Text [PDF 514 kb]   (399 Downloads) |   |   Full-Text (HTML)  (216 Views)  
Type of Study: Letter to Editor | Subject: Natural products

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb